The effects of oxiracetam (ISF 2522) in patients with organic brain syndrome (a double-blind controlled study with piracetam)
Notes for this study:
|Number of Subjects||60|
400mg piracetam (building up to a dose of 2,400mg over 6 weeks, and then maintained for another 6 weeks) was able to reduce symptoms of cognitive decline with particular efficacy towards reducing agitation. While it promoted memory formation, it was less effective than oxiracetam.